|
시장보고서
상품코드
2102100
치질 시장 규모, 점유율, 성장 분석 : 질환별, 치료법별, 투여 경로별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Hemorrhoids Market Size, Share, and Growth Analysis, By Disease Type (Internal Hemorrhoids, External Hemorrhoids), By Treatment Type, By Route of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 치질 시장 규모는 2024년에 55억 4,000만 달러로 평가되었으며, 2025년 58억 달러에서 2033년까지 83억 6,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 4.68%로 성장할 것으로 전망됩니다.
세계 치질 시장에는 전 세계 성인의 약 15%가 앓고 있는 치질을 대상으로 한 의약품, 의료기기 및 일반의약품이 포함됩니다. 치질 질환의 만성적인 특성과 높은 재발률이 그 중요성을 뒷받침하고 있을 뿐만 아니라, 입원 기간을 단축하는 최소침습 치료에 대한 수요가 증가하고 있습니다. 고령화의 진전이 시장 수요를 견인하고 있으며, 노화에 따른 혈관 문제로 인해 치질 사례가 증가하고 치료법 선택지가 급증하고 있습니다. 이러한 인구통계학적 변화로 인해, 수술 후 통증을 완화하는 것으로 알려진 동결 절제 카테터와 같은 혁신적인 의료기기에 대한 투자가 촉진되고 있습니다. 또한, 제조사와 소화기내과 클리닉이 제휴하여 종합적인 치료 경로를 구축함으로써 종합적인 치료 옵션이 제공되고 있으며, 이는 의약품 판매 이외의 수익 확대로 이어지고 있습니다. 고령화, 기술 발전, 통합된 서비스의 융합은 시장의 기존 기업과 신생 기업 모두에게 큰 성장 가능성을 보여주고 있습니다.
세계 치질 시장을 견인하는 요인
세계 치질 시장은 장시간 앉아 있는 생활 습관, 불건강한 식생활, 소화기 건강에 대한 인식 제고 등의 요인의 영향을 받아 성인의 치질 유병률이 증가함에 따라 성장하고 있습니다. 이러한 인식의 확산으로 인해 불편함을 호소하며 의료기관을 찾는 사람이 늘어나고 있으며, 그 결과 이용 가능한 치료법에 대한 잠재적 환자층이 확대되고 있습니다. 의료 종사자들이 치질 문제를 진단하기 위해 적극적인 접근 방식을 채택함에 따라 다양한 의약품 및 시술에 대한 수요가 증가하고 있습니다. 이러한 추세에 따라 제조사들은 제품 혁신과 라인업 확충을 촉진하는 한편, 의료 서비스 제공자들은 예방적 검진 및 치료 옵션에 대한 자원 배분을 점점 더 늘리고 있으며, 이는 시장 성장을 더욱 뒷받침하고 있습니다.
세계 치질 시장의 제약요인
세계 치질 시장은 초기 증상에 대한 인식 부족으로 인한 중대한 과제에 직면해 있으며, 이는 조기 진단을 저해하고 있습니다. 많은 사람들이 불편함을 느끼면서도 치료를 받기를 꺼리기 때문에 환자 수가 감소하고, 이용 가능한 치료법에 대한 수요도 줄어들고 있습니다. 이러한 상황은 다양한 인구통계학적 집단 간의 교육 격차로 인해 더욱 악화되고 있으며, 기존 의료 솔루션이 충분히 활용되지 못해 시장 침투 속도가 둔화되고 있습니다. 게다가 공중보건 캠페인은 고위험군을 효과적으로 대상으로 삼지 못하는 경우가 많아, 그 결과 예방 조치나 조기 진단의 중요성에 대한 인식이 확산되지 못하고 있으며, 이는 궁극적으로 시장 전체의 성장과 효과적인 치료법의 보급을 저해하고 있습니다.
세계 치질 시장 동향
세계 치질 시장에서는 최소침습 기술의 도입을 향한 뚜렷한 추세가 나타나고 있으며, 이는 치료 패러다임을 근본적으로 변화시키고 있습니다. 임상의들은 수술 후 불편감을 최소화하고 환자의 회복을 앞당기는 시술을 점점 더 많이 선택하고 있습니다. 첨단 고무밴드 결찰법, 레이저 응고 시스템, 고주파 절제술과 같은 혁신적인 기술이 외래 진료 현장에서 보편화되고 있어, 입원 없이도 치료를 효율적으로 진행할 수 있게 되었습니다. 이러한 변화의 배경에는 회복 기간 단축을 원하는 환자들의 요구가 높아지고 있는 점과, 높은 치료 성과와 환자 만족도 향상을 확보하면서도 시술 비용을 절감하려는 의료 제공자들의 노력이 있으며, 결국 최소침습적 접근법이 치질 치료의 표준 치료법으로 자리 잡아가고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 치질 시장 규모 : 질환 유형별
세계의 치질 시장 규모 : 치료 유형별
세계의 치질 시장 규모 : 투여 경로별
세계의 치질 시장 규모 : 유통 채널별
세계의 치질 시장 규모 : 최종사용자별
세계의 치질 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.03Global Hemorrhoids Market size was valued at USD 5.54 Billion in 2024 and is poised to grow from USD 5.8 Billion in 2025 to USD 8.36 Billion by 2033, growing at a CAGR of 4.68% during the forecast period (2026-2033).
The global hemorrhoids market encompasses pharmaceuticals, medical devices, and over-the-counter solutions targeting piles, which affect approximately fifteen percent of adults worldwide. The chronic nature of hemorrhoidal disease and high recurrence rates underpin its significance, alongside a growing preference for minimally invasive treatments that reduce hospital stays. The expanding aging population drives market demand, as age-related vascular issues increase hemorrhoidal cases, leading to a surge in therapeutic options. This demographic shift promotes investments in innovative devices, such as cryo-ablation catheters known for mitigating postoperative pain. Furthermore, partnerships between manufacturers and gastroenterology clinics to create bundled care pathways offer comprehensive treatment options, enhancing revenue beyond drug sales. This convergence of aging populations, technological advancements, and integrated services presents substantial growth potential for both established and emerging players in the market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemorrhoids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Hemorrhoids Market Segments Analysis
Global hemorrhoids market is segmented by disease type, treatment type, route of administration, distribution channel, end user and region. Based on disease type, the market is segmented into Internal Hemorrhoids, External Hemorrhoids and Mixed Hemorrhoids. Based on treatment type, the market is segmented into Conservative Treatment (Dietary Fiber, Stool Softeners, Lifestyle Modification), Pharmacological Treatment, Minimally Invasive Procedures and Surgical Procedures. Based on route of administration, the market is segmented into Topical, Oral and Injectable. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Hemorrhoids Market
The global hemorrhoids market is experiencing growth due to the increasing prevalence of the condition among adults, influenced by factors such as sedentary lifestyles, unhealthy dietary choices, and heightened awareness regarding gastrointestinal health. This surge in awareness has led more individuals to seek medical attention for their discomfort, thereby broadening the potential patient base for available treatments. As healthcare professionals adopt proactive approaches to diagnose hemorrhoidal issues, there is a growing demand for various pharmaceutical and procedural interventions. This trend encourages manufacturers to innovate and expand their product offerings, while healthcare providers increasingly allocate resources toward preventive screenings and treatment options, further fueling market growth.
Restraints in the Global Hemorrhoids Market
The global hemorrhoids market faces significant challenges due to limited awareness of early symptoms, which hampers prompt diagnosis. Many individuals experience discomfort but do not seek treatment, resulting in a reduced patient pool and diminished demand for available therapies. This situation is exacerbated by educational gaps across different demographic groups, leading to the underutilization of existing medical solutions and slowing market penetration. Furthermore, public health campaigns often fail to effectively target high-risk populations, leaving them unaware of preventive measures and the importance of early evaluation, ultimately hindering overall market growth and adoption of effective treatments.
Market Trends of the Global Hemorrhoids Market
The Global Hemorrhoids market is witnessing a significant trend towards the adoption of minimally invasive technologies, fundamentally altering treatment paradigms. Clinicians are increasingly opting for procedures that minimize postoperative discomfort and expedite recovery for patients. Innovations such as advanced rubber band ligation, laser coagulation systems, and radiofrequency ablation are becoming commonplace in outpatient settings, streamlining care without the need for hospitalization. This shift is motivated by a growing patient preference for quicker recovery times and healthcare providers' efforts to reduce procedural costs while ensuring high therapeutic outcomes and enhanced patient satisfaction, ultimately positioning minimally invasive approaches as the standard of care in managing hemorrhoids.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Hemorrhoids Market Size by Disease Type & CAGR (2026-2033)
- Market Overview
- Internal Hemorrhoids
- External Hemorrhoids
- Mixed Hemorrhoids
Global Hemorrhoids Market Size by Treatment Type & CAGR (2026-2033)
- Market Overview
- Conservative Treatment (Dietary Fiber, Stool Softeners, Lifestyle Modification)
- Pharmacological Treatment
- Topical Medications
- Oral Medications
- Others
- Minimally Invasive Procedures
- Rubber Band Ligation
- Sclerotherapy
- Infrared Coagulation
- Others
- Surgical Procedures
- Hemorrhoidectomy
- Stapled Hemorrhoidopexy
- Doppler-Guided Hemorrhoidal Artery Ligation (DG-HAL)
- Others
Global Hemorrhoids Market Size by Route of Administration & CAGR (2026-2033)
- Market Overview
- Topical
- Oral
- Injectable
Global Hemorrhoids Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Hemorrhoids Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- Home Care Settings
Global Hemorrhoids Market Size & CAGR (2026-2033)
- North America (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
- US
- Canada
- Europe (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Pfizer Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson Services Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viatris Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sandoz International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lupin Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dr Reddys Laboratories Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ConMed Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
